|
1
|
McDonagh TA, Metra M, Adamo M, Gardner RS,
Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et
al: 2021 ESC Guidelines for the diagnosis and treatment of acute
and chronic heart failure: Developed by the Task Force for the
diagnosis and treatment of acute and chronic heart failure of the
European Society of Cardiology (ESC). With the special contribution
of the Heart Failure Association (HFA) of the ESC. Eur J Heart
Fail. 24:4–131. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
McDonagh TA, Metra M, Adamo M, Gardner RS,
Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et
al: 2023 Focused update of the 2021 ESC Guidelines for the
diagnosis and treatment of acute and chronic heart failure. Eur
Heart J. 44:3627–3639. 2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Roger VL: Epidemiology of heart failure: A
contemporary perspective. Circ Res. 128:1421–1434. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mulder BA, van Veldhuisen DJ and Rienstra
M: Sudden cardiac death in heart failure: More than meets the eye.
Eur J Heart Fail. 23:1361–1363. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Elming MB, Hammer-Hansen S, Voges I,
Nyktari E, Raja AA, Svendsen JH, Pehrson S, Signorovitch J, Køber
L, Prasad SK, et al: Myocardial fibrosis and the effect of primary
prophylactic defibrillator implantation in patients with
non-ischemic systolic heart failure-DANISH-MRI. Am Heart J.
221:165–176. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jilek C, Lewalter T, Pauschinger M, von
Scheidt W, Frankenstein L, Pfister O, Hambrecht R, Bruder O,
Brachmann J, Hartmann A, et al: Cardioverter-defibrillator does not
improve short-term survival among patients with non-ischemic
cardiomyopathy and reduced left ventricular ejection fraction. Clin
Res Cardiol. 109:115–123. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Merkel ED, Schwertner WR, Behon A, Kuthi
L, Veres B, Osztheimer I, Papp R, Molnár L, Zima E, Gellér L, et
al: Predicting the survival benefit of cardiac resynchronization
therapy with defibrillator function for non-ischemic heart
failure-Role of the Goldenberg risk score. Front Cardiovasc Med.
9(1062094)2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wasiak M, Tajstra M, Kosior D and Gąsior
M: An implantable cardioverter-defibrillator for primary prevention
in non-ischemic cardiomyopathy: A systematic review and
meta-analysis. Cardiol J. 30:117–124. 2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Halliday BP, Cleland JGF, Goldberger JJ
and Prasad SK: Personalizing risk stratification for sudden death
in dilated cardiomyopathy: The past, present, and future.
Circulation. 136:215–231. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Escobar-Lopez L, Ochoa JP, Mirelis JG,
Espinosa MÁ, Navarro M, Gallego-Delgado M, Barriales-Villa R,
Robles-Mezcua A, Basurte-Elorz MT, Gutiérrez García-Moreno L, et
al: Association of genetic variants with outcomes in patients with
nonischemic dilated cardiomyopathy. J Am Coll Cardiol.
78:1682–1699. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rai V and Agrawal DK: Role of risk
stratification and genetics in sudden cardiac death. Can J Physiol
Pharmacol. 95:225–238. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tamariz L, Balda J, Pareja D, Palacio A,
Myerburg RJ, Conway D, Davis L and Goldberger JJ: Usefulness of
single nucleotide polymorphisms as predictors of sudden cardiac
death. Am J Cardiol. 123:1900–1905. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li S, Jia Z, Zhang Z, Li Y, Yan M and Yu
T: Association study of genetic variants in calcium
signaling-related genes with cardiovascular diseases. Front Cell
Dev Biol. 9(642141)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Arvanitis DA, Vafiadaki E, Johnson DM,
Kranias EG and Sanoudou D: The histidine-rich calcium binding
protein in regulation of cardiac rhythmicity. Front Physiol.
9(1379)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hofmann SL, Topham M, Hsieh CL and Francke
U: cDNA and genomic cloning of HRC, a human sarcoplasmic reticulum
protein, and localization of the gene to human chromosome 19 and
mouse chromosome 7. Genomics. 9:656–669. 1991.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pollak AJ, Haghighi K, Kunduri S,
Arvanitis DA, Bidwell PA, Liu GS, Singh VP, Gonzalez DJ, Sanoudou
D, Wiley SE, et al: Phosphorylation of serine96 of histidine-rich
calcium-binding protein by the Fam20C kinase functions to prevent
cardiac arrhythmia. Proc Natl Acad Sci USA. 114:9098–9103.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Han P, Cai W, Wang Y, Lam CK, Arvanitis
DA, Singh VP, Chen S, Zhang H, Zhang R, Cheng H, et al:
Catecholaminergic-induced arrhythmias in failing cardiomyocytes
associated with human HRCS96A variant overexpression. Am J Physiol
Heart Circ Physiol. 301:H1588–H1595. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Singh VP, Rubinstein J, Arvanitis DA, Ren
X, Gao X, Haghighi K, Gilbert M, Iyer VR, Kim DH, Cho C, et al:
Abnormal calcium cycling and cardiac arrhythmias associated with
the human Ser96Ala genetic variant of histidine-rich
calcium-binding protein. J Am Heart Assoc.
2(e000460)2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tzimas C, Johnson DM, Santiago DJ,
Vafiadaki E, Arvanitis DA, Davos CH, Varela A, Athanasiadis NC,
Dimitriou C, Katsimpoulas M, et al: Impaired calcium homeostasis is
associated with sudden cardiac death and arrhythmias in a genetic
equivalent mouse model of the human HRC-Ser96Ala variant.
Cardiovasc Res. 113:1403–1417. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Arvanitis DA, Sanoudou D, Kolokathis F,
Vafiadaki E, Papalouka V, Kontrogianni-Konstantopoulos A,
Theodorakis GN, Paraskevaidis IA, Adamopoulos S, Dorn GW II, et al:
The Ser96Ala variant in histidine-rich calcium-binding protein is
associated with life-threatening ventricular arrhythmias in
idiopathic dilated cardiomyopathy. Eur Heart J. 29:2514–2525.
2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Klappa AJ, Aleong R, Vargas-Estrada A,
Morgan G and London B: Abstract 20362: The Ser96Ala variant of the
histidine-rich calcium-binding protein is associated with
appropriate ICD shocks in cardiomyopathy patients. Circulation.
130(A20362)2014.
|
|
22
|
Galati F, Galati A and Massari S: RyR2
QQ2958 genotype and risk of malignant ventricular arrhythmias.
Cardiol Res Pract. 2016(2868604)2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mahmood A, Ahmed K and Zhang Y:
β-Adrenergic receptor desensitization/down-regulation in heart
failure: A friend or foe? Front Cardiovasc Med.
9(925692)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ahles A and Engelhardt S: Polymorphic
variants of adrenoceptors: Pharmacology, physiology, and role in
disease. Pharmacol Rev. 66:598–637. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bencivenga L, Liccardo D, Napolitano C,
Visaggi L, Rengo G and Leosco D: β-adrenergic receptor signaling
and heart failure: From bench to bedside. Heart Fail Clin.
15:409–419. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Thomas CD and Johnson JA: Pharmacogenetic
factors affecting β-blocker metabolism and response. Expert Opin
Drug Metab Toxicol. 16:953–964. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
McCrink KA and Lymperopoulos A:
β1-adrenoceptor Arg389Gly polymorphism and heart disease: Marching
toward clinical practice integration. Pharmacogenomics.
16:1035–1038. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Keefe JA, Moore OM, Ho KS and Wehrens XHT:
Role of Ca2+ in healthy and pathologic cardiac function: From
normal excitation-contraction coupling to mutations that cause
inherited arrhythmia. Arch Toxicol. 97:73–92. 2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Benitah JP, Perrier R, Mercadier JJ,
Pereira L and Gómez AM: RyR2 and calcium release in heart failure.
Front Physiol. 12(734210)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Koop A, Goldmann P, Chen SR, Thieleczek R
and Varsányi M: ARVC-related mutations in divergent region 3 alter
functional properties of the cardiac ryanodine receptor. Biophys J.
94:4668–4677. 2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang J, Liu Z, Masumiya H, Wang R, Jiang
D, Li F, Wagenknecht T and Chen SR: Three-dimensional localization
of divergent region 3 of the ryanodine receptor to the clamp-shaped
structures adjacent to the FKBP binding sites. J Biol Chem.
278:14211–14218. 2003.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Francia P, Adduci C, Semprini L, Stanzione
R, Serdoz A, Caprinozzi M, Santini D, Cotugno M, Palano F, Musumeci
MB, et al: RyR2 common gene variant G1886S and the risk of
ventricular arrhythmias in ICD patients with heart failure. J
Cardiovasc Electrophysiol. 26:656–661. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ran Y, Chen J, Li N, Zhang W, Feng L, Wang
R, Hui R, Zhang S and Pu J: Common RyR2 variants associate with
ventricular arrhythmias and sudden cardiac death in chronic heart
failure. Clin Sci. 119:215–223. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pimentel M, Zimerman A, Chemello D,
Giaretta V, Andrades M, Silvello D, Zimerman L and Rohde LE:
Predictors of serious arrhythmic events in patients with
nonischemic heart failure. J Interv Card Electrophysiol.
48:131–139. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kochi AN, Pimentel M, Andrades M, Zimerman
T, Zimerman LI and Rohde LE: Predictors of total mortality and
serious arrhythmic events in non-ischemic heart failure patients:
The role of galectin-3. Arq Bras Cardiol. 117:531–541.
2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lahiri DK and Nurnberger JI Jr: A rapid
non-enzymatic method for the preparation of HMW DNA from blood for
RFLP studies. Nucleic Acids Res. 19(5444)1991.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Griffiths A, Doebley J, Peichel C and
Wassarman DA: Introduction to genetic analysis. Macmillan, New
York, 12th ed., 2020.
|
|
38
|
Abramson JH: WINPEPI updated: Computer
programs for epidemiologists, and their teaching potential.
Epidemiol Perspect Innov. 8(1)2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Biolo A, Clausell N, Santos KG, Salvaro R,
Ashton-Prolla P, Borges A and Rohde LE: Impact of beta1-adrenergic
receptor polymorphisms on susceptibility to heart failure,
arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Am J Cardiol. 102:726–732. 2008.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Biolo A, Salvaro R, Clausell N, Silvello
D, Santos KG and Rohde LE: Impact of beta-2 Thr164Ile and combined
beta-adrenergic receptor polymorphisms on prognosis in a cohort of
heart failure outpatients. Braz J Med Biol Res. 43:565–571.
2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Chemello D, Rohde LE, Santos KG, Silvello
D, Goldraich L, Pimentel M, Rosa PR, Zimerman L and Clausell N:
Genetic polymorphisms of the adrenergic system and implantable
cardioverter-defibrillator therapies in patients with heart
failure. Europace. 12:686–691. 2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Liu WN, Fu KL, Gao HY, Shang YY, Wang ZH,
Jiang GH, Zhang Y, Zhang W and Zhong M: β1 adrenergic receptor
polymorphisms and heart failure: A meta-analysis on susceptibility,
response to β-blocker therapy and prognosis. PLoS One.
7(e37659)2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
de Groote P, Lamblin N, Helbecque N,
Mouquet F, Mc Fadden E, Hermant X, Amouyel P, Dallongeville J and
Bauters C: The impact of beta-adrenoreceptor gene polymorphisms on
survival in patients with congestive heart failure. Eur J Heart
Fail. 7:966–973. 2005.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Kardia SL, Kelly RJ, Keddache MA, Aronow
BJ, Grabowski GA, Hahn HS, Case KL, Wagoner LE, Dorn GW II and
Liggett SB: Multiple interactions between the alpha 2C- and
beta1-adrenergic receptors influence heart failure survival. BMC
Med Genet. 9(93)2008.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sehnert AJ, Daniels SE, Elashoff M,
Wingrove JA, Burrow CR, Horne B, Muhlestein JB, Donahue M, Liggett
SB, Anderson JL, et al: Lack of association between adrenergic
receptor genotypes and survival in heart failure patients treated
with carvedilol or metoprolol. J Am Coll Cardiol. 52:644–651.
2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ogimoto A, Okayama H, Nagai T, Suzuki J,
Inoue K, Nishimura K, Shigematsu Y, Tabara Y, Miki T and Higaki J:
Impact of synergistic polymorphisms in adrenergic receptor-related
genes and cardiovascular events in patients with dilated
cardiomyopathy. Circ J. 76:2003–2008. 2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Pezzali N, Curnis A, Specchia C, Carubelli
V, Covolo L, Donato F, Auricchio A, Regoli F and Metra M:
Adrenergic receptor gene polymorphism and left ventricular reverse
remodelling after cardiac resynchronization therapy: Preliminary
results. Europace. 15:1475–1481. 2013.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Zanolla L, Guarise P, Tomasi L, Vassanelli
C, Cicorella N, Zanini R, Guarrera S, Fiorito G and Matullo G:
Association between beta1-adrenergic receptor polymorphism and risk
of ICD shock in heart failure patients. Pacing Clin Electrophysiol.
39:557–564. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Pereira SB, Velloso MW, Chermont S,
Quintão MM, Nunes Abdhala R, Giro C, Oliveira E, Alves T, Camacho
V, De Fátima Maia Contarato L, Pena FM, et al: β-adrenergic
receptor polymorphisms in susceptibility, response to treatment and
prognosis in heart failure: Implication of ethnicity. Mol Med Rep.
7:259–265. 2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Parikh KS, Fiuzat M, Davis G, Neely M,
Blain-Nelson P, Whellan DJ, Abraham WT, Adams KF Jr, Felker GM,
Liggett SB, et al: Dose response of β-blockers in adrenergic
receptor polymorphism genotypes. Circ Genom Precis Med.
11(e002210)2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Cresci S, Kelly RJ, Cappola TP, Diwan A,
Dries D, Kardia SL and Dorn GW II: Clinical and genetic modifiers
of long-term survival in heart failure. J Am Coll Cardiol.
54:432–444. 2009.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Petersen M, Andersen JT, Hjelvang BR,
Broedbaek K, Afzal S, Nyegaard M, Børglum AD, Stender S, Køber L,
Torp-Pedersen C, et al: Association of beta-adrenergic receptor
polymorphisms and mortality in carvedilol-treated chronic
heart-failure patients. Br J Clin Pharmacol. 71:556–565.
2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Guerra LA, Lteif C, Arwood MJ, McDonough
CW, Dumeny L, Desai AA, Cavallari LH and Duarte JD: Genetic
polymorphisms in ADRB2 and ADRB1 are associated with differential
survival in heart failure patients taking β-blockers.
Pharmacogenomics J. 22:62–68. 2022.PubMed/NCBI View Article : Google Scholar
|
